Mr. Chair, I am not impressed by the pharmaceutical companies. I work for patients who want access to their medications and to new medications. That is really important to me. I want us to find points of convergence in this topic.
The government has said that it could provide a technical briefing. It seems to me that questions should be handled in a technical briefing, but not by taking time away from all those who have submitted briefs, who have asked to appear, who want to meet with us and who have not had the opportunity to be heard.
I do not want us taking time to ask technical questions about the PMPRB. That can be done in a technical briefing. I propose that we ask the technical questions to the officials who are looking after this reform in a technical briefing. I propose that we start hearing from witnesses right away and that we send in our list of witnesses.
In the first session, we can hear from eight witnesses. If each party were to propose two witnesses, we could organize a session right now! We have the list of people who have asked to appear as well as the briefs they have submitted. We could do all that. I propose that we have a technical briefing and that we hear from the groups and the witnesses, starting on Monday.